One year after having COVID, loss of smell remains in 1 in 3 patients
Long COVID involves significant limitations in terms of quality of life, including among young people. One of the sequelae that has the greatest impa1
Long COVID involves significant limitations in terms of quality of life, including among young people. One of the sequelae that has the greatest impa1
The findings open a new conceptual framework to understand the striking context-dependent pharmacological actions of cannabis in the brain.
A trial carried out entirely in Catalonia has shown that therapy with dolutegravir plus lamivudine has an efficacy similar to that of triple therapy.1
The study, led by CIBERES, included the participation of IDIBAPS and was published in the Journal of Internal Medicine.
The transparency agreement on the use of animals in scientific experimentation in Spain is a document promoted by the Spanish Confederation of S1
The flash system for continuous glucose monitoring (CGM) in interstitial fluid has been a major breakthrough for people with diabetes, in terms of bo1
A study by CIBERSAM with the participation of Hospital Clínic-IDIBAPS found that treatment-resistant depression has a mean incidence in Spain of1
Researchers from the CLÍNIC-IDIBAPS, the Hospital Universitari Vall d’Hebron and the Parc Taulí de Sabadell have shown the damage caused by the SARS-1
The Hospital Clínic has shown the key role played by Intermediate Respiratory Intensive Care Units (IRICUs) for the recovery and reduction in mortali1
Interview with Dr. Jacobo Sellarés, Head of the Interstitial Lung Disease Working Group. Pulmonology and Respiratory Allergy Service at the Hospital1